STAT

BIO in 30 Seconds

Dispatches from the BIO International Convention in San Diego.

We are on the ground in San Diego! Follow us on Twitter for more updates: @damiangarde@rebeccadrobbins@megkesh, and of course, @statnews

Making up for past snubs

Massachusetts Gov.(which is basically an extension of his predecessor’s 10-year, $1 billion program to promote life sciences). He’ll also be trying to get a sense of how these BIO bashes work: Boston is slated to host next year’s confab.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Amylyx Pulling Its ALS Drug, GLP-1 Drugs For Parkinson’s, And More
Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.

Related Books & Audiobooks